ARLINGTON PARTNERS LLC – Novo Nordisk A/S Transaction History
ARLINGTON PARTNERS LLC portfolio value:
$1.99M
portfolio value
ARLINGTON PARTNERS LLC quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.64% | 323 shares | -200K | $99.63 | 19.98K |
| Q2 2022 | share | Decrease | -20.25% | -4.99K shares | -547K | $111.43 | 19.66K |
| Q1 2022 | share | Decrease | -12.98% | -3.67K shares | -435K | $111.05 | 24.65K |
| Q4 2021 | share | Decrease | -12.26% | -3.95K shares | 73K | $111.45 | 28.33K |
| Q3 2021 | share | Decrease | -24.79% | -10.64K shares | -496K | $96.01 | 32.28K |
| Q2 2021 | share | Increase | +2.39% | 1.00K shares | 769K | $83.32 | 42.93K |
| Q1 2021 | share | Increase | +18.30% | 6.48K shares | 351K | $67.06 | 41.92K |
| Q4 2020 | share | Increase | +1.19% | 418 shares | 44K | $68.52 | 35.44K |
| Q3 2020 | share | 0.00% | 0 shares | 138K | $68.1 | 35.02K | |
| Q2 2020 | share | Decrease | -9.14% | -3.52K shares | -27K | $63.73 | 35.02K |
| Q1 2020 | share | Increase | +401.64% | 30.86K shares | 1.87M | $58.59 | 38.55K |
| Q4 2019 | share | Increase | +28.83% | 1.72K shares | 137K | $55.56 | 7.68K |
| Q3 2019 | share | Decrease | -87.61% | -42.18K shares | -2.15M | $49.63 | 5.96K |
| Q2 2019 | share | Increase | +870.77% | 43.19K shares | 2.19M | $48.57 | 48.15K |
| Q1 2019 | share | Decrease | -82.25% | -22.99K shares | -1.02M | $49.78 | 4.96K |
| Q4 2018 | share | Increase | +2.53% | 690 shares | 3K | $43.17 | 27.95K |
| Q3 2018 | share | Increase | +1.41% | 380 shares | 45K | $44.17 | 27.26K |
| Q2 2018 | share | 0.00% | 0 shares | -84K | $43.22 | 26.88K | |
| Q1 2018 | share | Increase | +7.71% | 1.92K shares | -15K | $46.15 | 26.88K |
| Q4 2017 | share | Increase | 0.00% | 24.95K shares | 1.33M | $49.61 | 24.95K |